Page 235 - Read Online

Singh et al. Myocardial protection in cardiac transplantation

with cardiopulmonary collapse. J Korean Med Sci 2015;30:1911-4. replacement therapy. J Heart Lung Transplant 1994;13:681-7;
87. Cooper LB, Milano CA, Williams M, Swafford W, Croezen D, Van discussion 685-7.
Bakel AB, Rogers JG, Patel CB. Thyroid hormone use during cardiac 106. Novitzky D, Mi Z, Sun Q, Collins JF, Cooper DK. Thyroid hormone
transplant organ procurement. Clin Transplant 2016;30:1578-83. therapy in the management of 63,593 brain-dead organ donors: a
88. Novitzky D, Cooper DK, Rosendale JD, Kauffman HM. Hormonal retrospective analysis. Transplantation 2014;98:1119-27.
therapy of the brain-dead organ donor: experimental and clinical 107. Macdonald PS, Aneman A, Bhonagiri D, Jones D, O’Callaghan G,
studies. Transplantation 2006;82:1396-401. Silvester W, Watson A, Dobb G. A systematic review and meta-
89. Novitzky D, Cooper DK, Wicomb W. Hormonal therapy to the brain- analysis of clinical trials of thyroid hormone administration to brain
dead potential organ donor: the misnomer of the “Papworth cocktail”. dead potential organ donors. Crit Care Med 2012;40:1635-44.
Transplantation 2008;86:1479. 108. Venkateswaran RV, Steeds RP, Quinn DW, Nightingale P, Wilson
90. Wheeldon DR, Potter CD, Oduro A, Wallwork J, Large SR. IC, Mascaro JG, Thompson RD, Townend JN, Bonser RS. The
Transforming the “unacceptable” donor: outcomes from the adoption haemodynamic effects of adjunctive hormone therapy in potential
of a standardized donor management technique. J Heart Lung heart donors: a prospective randomized double-blind factorially
Transplant 1995;14:734-42. designed controlled trial. Eur Heart J 2009;30:1771-80.
91. Wojda TR, Stawicki SP, Yandle KP, Bleil M, Axelband J, Wilde- 109. Novitzky D, Wicomb WN, Cooper DK, Tjaalgard MA. Improved
Onia R, Thomas PG, Cipolla J, Hoff WS, Shultz J. Keys to successful cardiac function following hormonal therapy in brain dead pigs:
organ procurement: an experience-based review of clinical practices relevance to organ donation. Cryobiology 1987;24:1-10.
at a high-performing health-care organization. Int J Crit Illn Inj Sci 110. Votapka TV, Canvasser DA, Pennington DG, Koga M, Swartz
2017;7:91-100. MT. Effect of triiodothyronine on graft function in a model of heart
92. Hahnenkamp K, Böhler K, Wolters H, Wiebe K, Schneider D, transplantation. Ann Thorac Surg 1996;62:78-82.
Schmidt HH. Organ-protective intensive care in organ donors. Dtsch 111. Hing AJ, Hicks M, Garlick SR, Gao L, Kesteven SH, Faddy SC,
Arztebl Int 2016;113:552-8. Wilson MK, Feneley MP, Macdonald PS. The effects of hormone
93. Nicolas-Robin A, Barouk JD, Amour J, Coriat P, Riou B, Langeron resuscitation on cardiac function and hemodynamics in a porcine
O. Hydrocortisone supplementation enhances hemodynamic stability brain-dead organ donor model. Am J Transplant 2007;7:809-17.
in brain-dead patients. Anesthesiology 2010;112:1204-10. 112. Zimmerman EA, Nilaver G, Hou-Yu A, Silverman AJ. Vasopressinergic
94. Novitzky D, Cooper DK, Muchmore JS, Zuhdi N. Pituitary function and oxytocinergic pathways in the central nervous system. Fed Proc
in brain-dead patients. Transplantation 1989;48:1078-9. 1984;43:91-6.
95. Barnes PJ. Beta-adrenergic receptors and their regulation. Am J Respir 113. Yoshioka T, Sugimoto H, Uenishi M, Sakamoto T, Sadamitsu D,
Crit Care Med 1995;152:838-60. Sakano T, Sugimoto T. Prolonged hemodynamic maintenance by
96. Clemente G, Tuttolomondo A, Colomba D, Pecoraro R, Renda C, Della the combined administration of vasopressin and epinephrine in brain
Corte V, Maida C, Simonetta I, Pinto A. When sepsis affects the heart: death: a clinical study. Neurosurgery 1986;18:565-7.
a case report and literature review. World J Clin Cases 2015;3:743-50. 114. Blaine EM, Tallman RD Jr, Frolicher D, Jordan MA, Bluth LL, Howie
97. McLean KM, Duffy JY, Pandalai PK, Lyons JM, Bulcao CF, Wagner MB. Vasopressin supplementation in a porcine model of brain-dead
CJ, Akhter SA, Pearl JM. Glucocorticoids alter the balance between potential organ donors. Transplantation 1984;38:459-64.
pro- and anti-inflammatory mediators in the myocardium in a porcine 115. Rostron AJ, Avlonitis VS, Cork DM, Grenade DS, Kirby JA, Dark
model of brain death. J Heart Lung Transplant 2007;26:78-84. JH. Hemodynamic resuscitation with arginine vasopressin reduces
98. Guglin M. How to increase the utilization of donor hearts? Heart Fail lung injury after brain death in the transplant donor. Transplantation
Rev 2015;20:95-105. 2008;85:597-606.
99. Pandit RA, Zirpe KG, Gurav SK, Kulkarni AP, Karnath S, Govil D, 116. Chen JM, Cullinane S, Spanier TB, Artrip JH, John R, Edwards
Abhram B, Mehta Y, Gupta A, Hegde A, Patil V, Bhatacharya P, NM, Oz MC, Landry DW. Vasopressin deficiency and pressor
Dixit S, Samavedan S, Todi S. Management of potential organ donor: hypersensitivity in hemodynamically unstable organ donors.
Indian society of critical care medicine: position statement. Indian J Circulation 1999;100:II244-6.
Crit Care Med 2017;21:303-16. 117. Pennefather SH, Bullock RE, Mantle D, Dark JH. Use of low
100. Pinsard M, Ragot S, Mertes PM, Bleichner JP, Zitouni S, Cook F, dose arginine vasopressin to support brain-dead organ donors.
Pierrot M, Dube L, Menguy E, Lefèvre LM, Escaravage L, Dequin Transplantation 1995;59:58-62.
PF, Vignon P, Pichon N. Interest of low-dose hydrocortisone therapy 118. Kinoshita Y, Yahata K, Yoshioka T, Onishi S, Sugimoto T. Long-
during brain-dead organ donor resuscitation: the CORTICOME study. term renal preservation after brain death maintained with vasopressin
Crit Care 2014;18:R158. and epinephrine. Transpl Int 1990;3:15-8.
101. Dimopoulou I, Tsagarakis S, Anthi A, Milou E, Ilias I, Stavrakaki K, 119. Papadopoulos G, Sintou E, Siminelakis S, Koletsis E, Baikoussis NG,
Charalambidis C, Tzanela M, Orfanos S, Mandragos K, Thalassinos Apostolakis E. Perioperative infusion of low- dose of vasopressin for
N, Roussos C. High prevalence of decreased cortisol reserve in brain- prevention and management of vasodilatory vasoplegic syndrome in
dead potential organ donors. Crit Care Med 2003;31:1113-7. patients undergoing coronary artery bypass grafting-A double-blind
102. Dhar R, Cotton C, Coleman J, Brockmeier D, Kappel D, Marklin G, randomized study. J Cardiothorac Surg 2010;5:17.
Wright R. Comparison of high- and low-dose corticosteroid regimens 120. Calva E, Mújica A, Núñez R, Aoki K, Bisteni A, Sodi-Pallares D.
for organ donor management. J Crit Care 2013;28:111.e1-7. Mitochondrial biochemical changes and glucose-KCl-insulin solution
103. Novitzky D, Cooper DK, Chaffin JS, Greer AE, DeBault LE, Zuhdi in cardiac infarct. Am J Physiol 1966;211:71-6.
N. Improved cardiac allograft function following triiodothyronine 121. Opie LH, Bruyneel K, Owen P. Effects of glucose, insulin and
therapy to both donor and recipient. Transplantation 1990;49:311-6. potassium infusion on tissue metabolic changes within first hour of
104. Chen YF, Kobayashi S, Chen J, Redetzke RA, Said S, Liang Q, myocardial infarction in the baboon. Circulation 1975;52:49-57.
Gerdes AM. Short term triiodo-L-thyronine treatment inhibits cardiac 122. Sodi-pallares D, Testelli MR, Fishleder BL, Bisteni A, Medrano GA,
myocyte apoptosis in border area after myocardial infarction in rats. J Friedland C, De Micheli A. Effects of an intravenous infusion of a
Mol Cell Cardiol 2008;44:180-7. potassium-glucose-insulin solution on the electrocardiographic signs
105. Jeevanandam V, Todd B, Regillo T, Hellman S, Eldridge C, McClurken of myocardial infarction. A preliminary clinical report. Am J Cardiol
J. Reversal of donor myocardial dysfunction by triiodothyronine 1962;9:166-81.

228 Vessel Plus ¦ Volume 1 ¦ December 28, 2017